FDAnews Drug Daily Bulletin

Hoping for HIV Prevention (Pharmalot Blog)
Gilead Sciences is seeking approval from an FDA advisory panel for its Truvada HIV pill as a preventative drug. “The move was both welcomed and criticized by AIDS activists, reflecting a spectrum of views on making a preventive pill available on a large-scale basis,” blogger Ed Silverman writes. Some see this as a measure of helping to contain HIV. “To others, FDA approval raises the specter of creating a form of resistance to HIV due to widespread use,” Silverman adds.